Advertisement
Advertisement

GH

GH logo

Guardant Health, Inc. Common Stock

158.38
USD
Sponsored
-5.70
-3.47%
Jul 10, 12:28 UTC -4
Open

GH Earnings Reports

Positive Surprise Ratio

GH beat 14 of 31 last estimates.

45%

Next Report

Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$323.84M
/
-$0.40
Implied change from Q1 26 (Revenue/ EPS)
+7.35%
/
-11.11%
Implied change from Q2 25 (Revenue/ EPS)
+39.54%
/
-50.00%

Guardant Health, Inc. Common Stock earnings per share and revenue

On May 07, 2026, GH reported earnings of -0.45 USD per share (EPS) for Q1 26, beating the estimate of -0.51 USD, resulting in a 11.94% surprise. Revenue reached 301.67 million, compared to an expected 287.57 million, with a 4.90% difference. The market reacted with a +3.73% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 23 analysts forecast an EPS of -0.40 USD, with revenue projected to reach 323.84 million USD, implying an decrease of -11.11% EPS, and increase of 7.35% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q1 2026, Guardant Health, Inc. Common Stock reported EPS of -$0.45, beating estimates by 11.94%, and revenue of $301.67M, 4.9% above expectations.
The stock price moved up 3.73%, changed from $92.26 before the earnings release to $95.70 the day after.
The next earning report is scheduled for Jul 30, 2026.
Based on 23 analysts, Guardant Health, Inc. Common Stock is expected to report EPS of -$0.40 and revenue of $323.84M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement